The controlled-release oxycodone tablet formulation (OCRT) was approved in China in 2004 for management of moderate to severe cancer pain. Few data about the efficacy of OCRT and clinical outcomes ...

The National Agency for Food and Drug Administration and Control (NAFDAC) has issued a public alert warning of falsified ...

scores after administration of controlled-release oxycodone tablets to patients with moderate to severe cancer pain.

NSW Health is warning the community about the dangers of nitazenes following the detection of nitazenes in fake oxycodone tablets in NSW.The fake ...